CLINICAL TRIALS PROFILE FOR TESOFENSINE
✉ Email this page to a colleague
Clinical Trials for Tesofensine
Trial ID | Title | Status | Sponsor | Phase | Summary |
---|---|---|---|---|---|
NCT00148512 ↗ | A Randomized, Double-blind, Placebo-controlled, Five Parallel Groups Efficacy and Safety Study of NS 2330 (Tesofensine) (0.125 mg, 0.25 mg, 0.5 mg and 1.0 mg) Administered Orally Once Daily Over 14 Weeks in Levodopa Treated Parkinson Patients With M | Completed | Boehringer Ingelheim | Phase 2 | The primary objective of this exploratory study is to investigate the efficacy and safety of tesofensine in daily doses (from 0.125 mg to 1.0 mg) in comparison to placebo, over a 14-week treatment period in levodopa treated Parkinson patients with motor fluctuations. |
NCT00153010 ↗ | An Evaluation of Three Doses of NS 2330 in Patients With Mild to Moderate Dementia of the Alzheimer's Type | Completed | Boehringer Ingelheim | Phase 2 | Objectives: The objective of this study will be to determine the safety, tolerability, drug blood levels, and efficacy of each of three doses of NS 2330 (Tesofensine) given once daily compared with placebo in patients with mild to moderate Dementia of the Alzheimer's Type. |
NCT00394667 ↗ | Effect of Tesofensine on Weight Reduction in Patients With Obesity. | Completed | NeuroSearch A/S | Phase 2 | Purpose: To evaluate the efficacy on weight reduction, metabolic parameters and safety of tesofensine versus placebo in obese patients |
NCT00428415 ↗ | Effect of Tesofensine on Energy Balance in Humans. | Completed | NeuroSearch A/S | Phase 1/Phase 2 | Purpose: To evaluate the effect of tesofensine on energy balance |
NCT00481104 ↗ | Evaluation of Long Term Safety of Tesofensine in Patients With Obesity | Completed | NeuroSearch A/S | Phase 2 | Purpose of the study is to evaluate the long term safety of tesofensine in obese patients |
NCT02349243 ↗ | Effect of Entacapone on Bodyweight Loss in Obese Population | Unknown status | National Institute of Biological Sciences, Beijing | Phase 1/Phase 2 | This is a randomized, controlled, double blind clinical trial. The purpose of this study is to investigate the weight loss efficacy of entacapone. In this study, participants are randomly divided into entacapone and placebo groups. The percentage change in body weight, the body mass index, waist circumstance, extent of fatty liver, quantity of visceral fat, serum insulin, serum triglyceride and the adverse effects are compared between the two groups. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Summary |
Clinical Trial Conditions for Tesofensine
Condition Name
Clinical Trial Locations for Tesofensine
Trials by Country
Clinical Trial Progress for Tesofensine
Clinical Trial Phase
Clinical Trial Sponsors for Tesofensine
Sponsor Name